Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_assertion type Assertion NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_head.
- NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_assertion wasGeneratedBy ECO_0000203 NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_provenance.
- NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_assertion wasDerivedFrom befree-20140225 NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_provenance.
- NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_assertion SIO_000772 16987873 NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_provenance.
- NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_assertion evidence source_evidence_literature NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_provenance.
- NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_assertion description "[The first therapeutic treatments of animal models of mental retardation have been reported, a Drosophila model of Fragile X syndrome has been treated with lithium or metabotropic glutamate receptor (mGluR) antagonists and a mouse model of NF1 has been treated with the HMG-CoA reductase inhibitor lavastatin, which improves the learning and memory skills in these models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_provenance.